Research Institute of Molecular Pathology IMP
Funded primarily by Boehringer Ingelheim and with unconstrained academic freedom, the Research Institute of Molecular Pathology (IMP) is a leading institute for biomedical researchin Vienna, Austria.
Search
Hypertension
Hypertension
Reimagining digital healthcare worldwide
How does our digital lab BI X innovate in Ingelheim and Shanghai? Read about success stories based on different ideation processes
Immune cell directed therapies
Boehringer Ingelheim is committed to transforming cancer care, investigating therapies that target cancer cells and boost the immune system for the benefit of patients.
Oncology Translational Science
Discover how Boehringer Ingelheim leverages translational science to bridge pre-clinical research and clinical development, enhancing patient outcomes in oncology. Learn about our patient-centric strategies, biomarker discovery, and collaborative efforts
AI as an assistant in research and development
Boehringer Ingelheim is helping to shape AI development as a pioneer.
Cancer
At Boehringer Ingelheim we are dedicated to working on improving treatments for cancer patients everywhere with a focus on lung and gastrointestinal cancers.
Vision & Values
Vision & Values
Patient Safety & Pharmacovigilance at Boehringer Ingelheim
Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives.
Diabetes
Diabetes
Metabolic Diseases
Metabolic Diseases
Interstitial Lung Diseases - Sound the ILD Alarm
Learn more about ILDs and why it's important to ‘sound the ILD alarm’ for early detection and treatment.
EFPIA PO disclosure for year 2022 _ EN version
EFPIA PO disclosure for year 2022 _ SLO version
What is my role as a patient or a caregiver forpatient safety & pharmacovigilance
Informed decision and safe use of medications
What is being done for patient safety by different stakeholders
Ruminants
Ruminants
Unleashing Innovation at Boehringer Ingelheim
Join us at our upcoming seminar and networking event where we'll share our unique approach to fostering innovation and supporting startups. We're excited to introduce you to Research Beyond Borders, our approach to open science: opnMe.com
About Us
About Us
Science Stories
Science Stories
Fact & Figures Boehringer Ingelheim RCV
Facts and figures speak a clear language. Only economic success enables us to implement our corporate vision.
Veterinarians: caught between excellence and exhaustion
Many children dream of becoming a veterinarian. What happens when that dream comes true?
Animal Health Partnering Interests
Animal Health Partnering Interests
Science Focus
Our Science Focus at Boehringer Ingelheim